-25% recover completely
-continue more or less normal life with drug therapy.
Drug Therapy.
.Analgesia and NSAIDs
-mainly for symptoms control.
.Cortocosteroids.
-slows down the progress of the disease.(immunosupressants)
-intra-articular injections and i.m. depot injections.
.Disease Modifying Anti-Rheumatoid Drugs.(DMARDs)
Traditional DMARDs.
"Most Sufferers Can Get Appropriate Pain Control...Lol ".
M-methotrexate
S-sulfasalazine
C-ciclosporin
G-gold
A-azathioprine.
P-penicillamine
C-hydroxyChloroquine
L-leflunomide
Biological DMARDs.
-genetically engineered drugs – meaning that human genes that normally guide the production of these natural human immune proteins (i.e., an antibody to TNF) are used in non-human cell cultures to produce large amounts of a biologic drug.
-In these diseases, TNF or IL-1 act to increase inflammation, similar to the effect of gasoline on a fire.
-However, in rheumatoid arthritis TNF or IL-1 (the gasoline) acts to excite the inflamed joint (the fire).
-are very expensive
-so, they are used after at least 2 traditional DMARDs usually methotrexate and sulfasalazine.
1.TNF-alpha inhibitors.
-etanercept
-fully humanized p75 TNF-alphareceptor IgG1.
-25 mg 2 weekly or 50mg weekly, s.c
-Given S.C and self-administration.
-65% of patients respond well.
-adalimumab
-s.c 40mg alternate week
-fully humanized monoclonal antibody against TNF-alpha given along with methotrexate.
-infliximab
-i.v. 3-10mg/kg every 4-8 weeks.
-a monoclonal antibody against TNF-alpha
-co-prescribed with methotrexate
-given intravenously.
*These drugs slow or halt erosion formation upto 70% of patients with RA and produce healing in few.
*Chances of secondary failure, 50% with infliximab and less with etanercept and adalimumab.
Side Effects:
-Increased tumour development is controversial.
-ANA positive in few--->SLE, Leucocytoclastic vasculities, extracutaneous involvement or sinterstitial lung disease
-Reactivation of old TB, therefore pre-treatment chest x-ray recommended.
-increased risk of infection, so close monitoring required.
2.Cytokine IL-1 inhibitor.
-Anakinra
-a human recombinant IL-1 receptor antagonist.
-used along with methotrexate
-used after anti-TNF agents failure.
3.Others.
1.Rituximab
- a monoclonal Ab
-lysis of CD-positive B cells.
2.Abatacept
-modulates T cells activation.
3.Tocilizumab
-Anti-IL-6 receptor (clinically in trials now)
Drugs Used Less Commonly.
1.Gold- sodium aurothiomalate by deep I.M. injection
2.Hydroxychloroquine.- anti-malarial
-200-400mg daily alone in mild disease or as an adjunct to DMARDs.
-retinopathy is side effect.
3.Penicillamine-125g daily for 1 month and 500-750g daily before food for at least 3 months before improvement occurs.
-if proteinuria exceeds >2g/24h, it should be stopped.
-SLE and myasthenia gravis like syndrome occurs.
4.Azathioprine- max. dose of 2.5mg/kg and cyclophosphamide 1-2mg/kg usually when DMARDs are ineffective.
5.Ciclosporin
-2.5-4mg.kg
-used for active RA.
-s.e- hypertension and rise in creatinine level.
0 comments:
Post a Comment